首页> 外国专利> CONFORMATIONALLY RESTRICTED 4-SUBSTITUTED-2,6-DIMETHYLFURO2,3-dPYRIMIDINES AS ANTITUMOR AGENTS

CONFORMATIONALLY RESTRICTED 4-SUBSTITUTED-2,6-DIMETHYLFURO2,3-dPYRIMIDINES AS ANTITUMOR AGENTS

机译:构象受限的4-取代-2,6-二甲基呋喃[2,3- d ]吡嘧啶作为抗老剂

摘要

The present invention provides conformationally restricted 4-substituted 2,6-dimethylfuro[2,3-d]pyrimidine compounds and pharmaceutical compositions comprising these compounds. Preferably, the compounds exhibit dual inhibition of microtubule assembly and receptor tyrosine kinases. Methods of treating cancer comprising administering a therapeutically effective amount of at least one conformationally restricted 4-substituted 2,6-dimethylfuro[2,3-d]pyrimidine compound to a patient is disclosed.
机译:本发明提供了构象受限的4-取代的2,6-二甲基呋喃并[2,3- d ]嘧啶化合物。

著录项

  • 公开/公告号WO2016100495A1

    专利类型

  • 公开/公告日2016-06-23

    原文格式PDF

  • 申请/专利权人 DUQUESNE UNIVERSITY OF THE HOLY SPIRIT;

    申请/专利号WO2015US66062

  • 发明设计人 GANGJEE ALEEM;

    申请日2015-12-16

  • 分类号C07D491/048;A61K31/519;

  • 国家 WO

  • 入库时间 2022-08-21 14:17:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号